Kingdon Capital Management »

X4 Pharmaceuticals shares owned by Kingdon Capital Management

Quarter-by-quarter ownership of X4 Pharmaceuticals (XFOR) shares owned by Kingdon Capital Management from 13F filings

Historical chart of Kingdon Capital Management investment in X4 Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including X4 Pharmaceuticals held by Kingdon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in X4 Pharmaceuticals by Kingdon Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.2M 933k 3.42
2025-06-30 $443k 233k 1.90

More positions owned by Kingdon Capital Management

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Syndax Pharmaceuticals (SNDX)
Ishares Msci Sth Kor Etf (EWY)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
NVIDIA Corporation (NVDA)
Kkr & Co (KKR)
Molina Healthcare (MOH)
Soleno Therapeutics (SLNO)
Edwards Lifesciences (EW)
Nexgen Energy (NXE)
Humana (HUM)
Builders FirstSource (BLDR)
CRH Ord (CRH)
Hci (HCI)
Everus Constr Group (ECG)

View all positions for Kingdon Capital Management

Top funds holding X4 Pharmaceuticals

Bain Capital Life Sciences Investors
BVF
Nantahala Capital Management
Rosalind Advisors
Deep Track Capital
Stonepine Capital Management
Kingdon Capital Management
Stempoint Capital
Vanguard Group
Boothbay Fund Management
Pale Fire Capital SE
UBS Group
Susquehanna International
Palumbo Wealth Management
Geode Capital Management

View all funds holding X4 Pharmaceuticals